vs

Side-by-side financial comparison of Campbell's Company (The) (CPB) and ICAHN ENTERPRISES L.P. (IEP). Click either name above to swap in a different company.

ICAHN ENTERPRISES L.P. is the larger business by last-quarter revenue ($2.7B vs $2.7B, roughly 1.0× Campbell's Company (The)). Campbell's Company (The) runs the higher net margin — 7.2% vs 0.0%, a 7.2% gap on every dollar of revenue. On growth, ICAHN ENTERPRISES L.P. posted the faster year-over-year revenue change (5.4% vs -3.4%). Campbell's Company (The) produced more free cash flow last quarter ($97.0M vs $-496.0M). Over the past eight quarters, ICAHN ENTERPRISES L.P.'s revenue compounded faster (4.5% CAGR vs 4.4%).

The Campbell's Company is an American company, most closely associated with its flagship canned soup products. The classic red-and-white can design used by many Campbell's branded products has become an American icon, and its use in pop art was typified by American artist Andy Warhol's series of Campbell's Soup Cans prints.

Icahn Enterprises L.P. is an American publicly traded master limited partnership and conglomerate headquartered at Milton Tower in Sunny Isles Beach, Florida. The company has investments in various industries including energy, automotive, food packaging, metals, real estate and home fashion. The company is controlled by Carl Icahn, who owns 86 percent of it.

CPB vs IEP — Head-to-Head

Bigger by revenue
IEP
IEP
1.0× larger
IEP
$2.7B
$2.7B
CPB
Growing faster (revenue YoY)
IEP
IEP
+8.8% gap
IEP
5.4%
-3.4%
CPB
Higher net margin
CPB
CPB
7.2% more per $
CPB
7.2%
0.0%
IEP
More free cash flow
CPB
CPB
$593.0M more FCF
CPB
$97.0M
$-496.0M
IEP
Faster 2-yr revenue CAGR
IEP
IEP
Annualised
IEP
4.5%
4.4%
CPB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CPB
CPB
IEP
IEP
Revenue
$2.7B
$2.7B
Net Profit
$194.0M
$1.0M
Gross Margin
29.6%
Operating Margin
12.6%
0.6%
Net Margin
7.2%
0.0%
Revenue YoY
-3.4%
5.4%
Net Profit YoY
-11.0%
101.0%
EPS (diluted)
$0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPB
CPB
IEP
IEP
Q4 25
$2.7B
$2.7B
Q3 25
$2.3B
$2.7B
Q2 25
$2.5B
$2.4B
Q1 25
$2.7B
$1.9B
Q4 24
$2.8B
$2.6B
Q3 24
$2.3B
$2.8B
Q2 24
$2.4B
$2.2B
Q1 24
$2.5B
$2.5B
Net Profit
CPB
CPB
IEP
IEP
Q4 25
$194.0M
$1.0M
Q3 25
$145.0M
$287.0M
Q2 25
$66.0M
$-165.0M
Q1 25
$173.0M
$-422.0M
Q4 24
$218.0M
$-98.0M
Q3 24
$-3.0M
$22.0M
Q2 24
$133.0M
$-331.0M
Q1 24
$203.0M
$-38.0M
Gross Margin
CPB
CPB
IEP
IEP
Q4 25
29.6%
Q3 25
30.4%
Q2 25
29.4%
Q1 25
30.5%
Q4 24
31.3%
Q3 24
29.4%
Q2 24
30.9%
Q1 24
31.6%
Operating Margin
CPB
CPB
IEP
IEP
Q4 25
12.6%
0.6%
Q3 25
11.6%
19.7%
Q2 25
6.5%
-10.4%
Q1 25
12.2%
-35.0%
Q4 24
13.2%
-5.2%
Q3 24
3.4%
2.4%
Q2 24
10.5%
-21.9%
Q1 24
12.9%
-0.8%
Net Margin
CPB
CPB
IEP
IEP
Q4 25
7.2%
0.0%
Q3 25
6.2%
10.5%
Q2 25
2.7%
-7.0%
Q1 25
6.4%
-22.6%
Q4 24
7.9%
-3.8%
Q3 24
-0.1%
0.8%
Q2 24
5.6%
-15.0%
Q1 24
8.3%
-1.5%
EPS (diluted)
CPB
CPB
IEP
IEP
Q4 25
$0.65
Q3 25
$0.49
Q2 25
$0.22
Q1 25
$0.58
Q4 24
$0.72
Q3 24
$-0.01
Q2 24
$0.44
Q1 24
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPB
CPB
IEP
IEP
Cash + ST InvestmentsLiquidity on hand
$168.0M
$1.4B
Total DebtLower is stronger
$6.1B
Stockholders' EquityBook value
$4.0B
Total Assets
$15.2B
$14.2B
Debt / EquityLower = less leverage
1.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPB
CPB
IEP
IEP
Q4 25
$168.0M
$1.4B
Q3 25
$132.0M
$1.8B
Q2 25
$143.0M
$1.8B
Q1 25
$829.0M
$2.2B
Q4 24
$808.0M
$2.6B
Q3 24
$108.0M
$2.3B
Q2 24
$107.0M
$2.2B
Q1 24
$169.0M
$2.5B
Total Debt
CPB
CPB
IEP
IEP
Q4 25
$6.1B
Q3 25
$6.1B
Q2 25
$6.1B
Q1 25
$6.5B
Q4 24
$6.7B
Q3 24
$5.8B
Q2 24
$5.8B
Q1 24
$4.5B
Stockholders' Equity
CPB
CPB
IEP
IEP
Q4 25
$4.0B
Q3 25
$3.9B
Q2 25
$3.9B
Q1 25
$3.9B
Q4 24
$3.8B
Q3 24
$3.8B
Q2 24
$3.9B
Q1 24
$3.8B
Total Assets
CPB
CPB
IEP
IEP
Q4 25
$15.2B
$14.2B
Q3 25
$14.9B
$14.8B
Q2 25
$14.8B
$14.8B
Q1 25
$15.9B
$15.5B
Q4 24
$16.1B
$16.3B
Q3 24
$15.2B
$17.4B
Q2 24
$15.2B
$18.0B
Q1 24
$12.1B
$20.1B
Debt / Equity
CPB
CPB
IEP
IEP
Q4 25
1.54×
Q3 25
1.56×
Q2 25
1.58×
Q1 25
1.66×
Q4 24
1.75×
Q3 24
1.52×
Q2 24
1.47×
Q1 24
1.17×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPB
CPB
IEP
IEP
Operating Cash FlowLast quarter
$224.0M
$-421.0M
Free Cash FlowOCF − Capex
$97.0M
$-496.0M
FCF MarginFCF / Revenue
3.6%
-18.4%
Capex IntensityCapex / Revenue
4.7%
2.8%
Cash ConversionOCF / Net Profit
1.15×
-421.00×
TTM Free Cash FlowTrailing 4 quarters
$687.0M
$-654.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPB
CPB
IEP
IEP
Q4 25
$224.0M
$-421.0M
Q3 25
$259.0M
$15.0M
Q2 25
$135.0M
$275.0M
Q1 25
$512.0M
$-182.0M
Q4 24
$225.0M
$244.0M
Q3 24
$288.0M
$-54.0M
Q2 24
$213.0M
$893.0M
Q1 24
$510.0M
$-251.0M
Free Cash Flow
CPB
CPB
IEP
IEP
Q4 25
$97.0M
$-496.0M
Q3 25
$129.0M
$-67.0M
Q2 25
$50.0M
$179.0M
Q1 25
$411.0M
$-270.0M
Q4 24
$115.0M
$156.0M
Q3 24
$147.0M
$-112.0M
Q2 24
$100.0M
$827.0M
Q1 24
$390.0M
$-319.0M
FCF Margin
CPB
CPB
IEP
IEP
Q4 25
3.6%
-18.4%
Q3 25
5.6%
-2.5%
Q2 25
2.0%
7.6%
Q1 25
15.3%
-14.5%
Q4 24
4.1%
6.1%
Q3 24
6.4%
-4.0%
Q2 24
4.2%
37.6%
Q1 24
15.9%
-12.9%
Capex Intensity
CPB
CPB
IEP
IEP
Q4 25
4.7%
2.8%
Q3 25
5.6%
3.0%
Q2 25
3.4%
4.1%
Q1 25
3.8%
4.7%
Q4 24
4.0%
3.4%
Q3 24
6.1%
2.1%
Q2 24
4.8%
3.0%
Q1 24
4.9%
2.8%
Cash Conversion
CPB
CPB
IEP
IEP
Q4 25
1.15×
-421.00×
Q3 25
1.79×
0.05×
Q2 25
2.05×
Q1 25
2.96×
Q4 24
1.03×
Q3 24
-2.45×
Q2 24
1.60×
Q1 24
2.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPB
CPB

Baked Snacks$995.0M37%
Snacks$914.0M34%
Simple Meals$580.0M22%
Beverages$168.0M6%

IEP
IEP

Public Utilities Inventory Petroleum Products$1.6B61%
Other$381.0M14%
Automotive Services$345.0M13%
Nitrogen Fertilizer Products$131.0M5%
Food Packaging Segment$82.0M3%
Home Fashion Segment$45.0M2%
Renewable Products$32.0M1%
Pharma Segment$23.0M1%
Holding Company$11.0M0%

Related Comparisons